XFOR — X4 Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for X4 Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	81.8	122	114	102	253
Net Total Accounts Receivable
Net Total Receivables	0.747	1.15	0.562	1.71	0.573
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	87.9	129	122	112	262
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10.2	8.33	6.39	4.84	1.59
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	117	156	147	146	290
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14	22.3	22.9	32.9	25.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	52.8	81.5	96.2	124	104
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	64.4	74.1	51.1	22.1	186
Total Liabilities & Shareholders' Equity	117	156	147	146	290
Total Common Shares Outstanding